# Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension

> **NCT05545059** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 138 (estimated)

## Conditions studied

- Resistant Hypertension

## Interventions

- **DRUG:** Sacubitril/valsartan
- **DRUG:** valsartan

## Key facts

- **NCT ID:** NCT05545059
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-24
- **Primary completion:** 2022-10-28
- **Final completion:** 2023-03-31
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2022-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05545059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05545059, "Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT05545059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*